rs370388701
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BS1_Supporting
The NM_004370.6(COL12A1):c.2588G>A(p.Gly863Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000799 in 1,614,170 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004370.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL12A1 | ENST00000322507.13 | c.2588G>A | p.Gly863Glu | missense_variant | Exon 13 of 66 | 1 | NM_004370.6 | ENSP00000325146.8 | ||
COL12A1 | ENST00000345356.10 | c.74-22678G>A | intron_variant | Intron 2 of 50 | 1 | ENSP00000305147.9 | ||||
COL12A1 | ENST00000483888.6 | c.2588G>A | p.Gly863Glu | missense_variant | Exon 13 of 65 | 5 | ENSP00000421216.1 | |||
COL12A1 | ENST00000416123.6 | c.2588G>A | p.Gly863Glu | missense_variant | Exon 12 of 63 | 5 | ENSP00000412864.2 |
Frequencies
GnomAD3 genomes AF: 0.000440 AC: 67AN: 152160Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000100 AC: 25AN: 249512Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135368
GnomAD4 exome AF: 0.0000417 AC: 61AN: 1461892Hom.: 0 Cov.: 31 AF XY: 0.0000371 AC XY: 27AN XY: 727246
GnomAD4 genome AF: 0.000447 AC: 68AN: 152278Hom.: 0 Cov.: 32 AF XY: 0.000470 AC XY: 35AN XY: 74466
ClinVar
Submissions by phenotype
not provided Uncertain:2
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
- -
Inborn genetic diseases Uncertain:1
The c.2588G>A (p.G863E) alteration is located in exon 13 (coding exon 12) of the COL12A1 gene. This alteration results from a G to A substitution at nucleotide position 2588, causing the glycine (G) at amino acid position 863 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
COL12A1-related disorder Uncertain:1
The COL12A1 c.2588G>A variant is predicted to result in the amino acid substitution p.Gly863Glu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.19% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/6-75884876-C-T). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Bethlem myopathy 2;C4225314:Ullrich congenital muscular dystrophy 2 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at